4D Molecular Therapeutics, Inc.
FDMT
$9.48
-$0.39-3.95%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 402.66M | 305.06M | 293.23M | 321.44M | 424.88M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 10.48M | 7.31M | 10.06M | 11.13M | 10.06M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 413.13M | 312.38M | 303.29M | 332.57M | 434.93M |
|
|
|||||
| Total Current Assets | 413.13M | 312.38M | 303.29M | 332.57M | 434.93M |
| Net Property, Plant & Equipment | 33.01M | 35.06M | 37.15M | 39.12M | 40.61M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 9.19M | 9.38M | 9.39M | 7.04M | 4.26M |
| Total Assets | 566.71M | 423.98M | 473.64M | 515.73M | 560.38M |
|
|
|||||
| Total Accounts Payable | 11.16M | 6.86M | 8.70M | 4.15M | 4.39M |
| Total Accrued Expenses | 26.87M | 24.19M | 19.19M | 16.20M | 18.87M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.59M | 5.70M | 5.72M | 5.68M | 5.64M |
| Total Finance Division Other Current Liabilities | 360.00K | 360.00K | 1.07M | 866.00K | 257.00K |
| Total Other Current Liabilities | 360.00K | 360.00K | 1.07M | 866.00K | 257.00K |
| Total Current Liabilities | 43.99M | 37.11M | 34.68M | 26.90M | 29.15M |
|
|
|||||
| Total Current Liabilities | 43.99M | 37.11M | 34.68M | 26.90M | 29.15M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 15.82M | 16.57M | 17.36M | 18.17M | 18.97M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 1.24M | 1.32M | 714.00K | 933.00K | 1.66M |
| Total Liabilities | 61.05M | 55.00M | 52.75M | 46.01M | 49.78M |
|
|
|||||
| Common Stock & APIC | 1.22B | 1.10B | 1.10B | 1.09B | 1.09B |
| Retained Earnings | -716.30M | -735.70M | -678.83M | -624.17M | -576.20M |
| Treasury Stock & Other | 727.00K | 671.00K | 337.00K | 332.00K | 229.00K |
| Total Common Equity | 505.66M | 368.98M | 420.89M | 469.72M | 510.61M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 505.66M | 368.98M | 420.89M | 469.72M | 510.61M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 505.66M | 368.98M | 420.89M | 469.72M | 510.61M |
|
|
|||||